Waleed H. Hassanein, President & CEO at TransMedics Group, Inc. (TMDX), sold 15,545 shares at $167.24 ($2.6M) on 2024-08-15, disclosed to the SEC on 2024-08-19.
Scheduled sale ($2.6M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $165.26 | 300 | $50K | 1.9% |
| 2 | $167.24 | 700 | $117K | 4.4% |
| 3 | $168.17 | 500 | $84K | 3.2% |
| 4 | $169.39 | 1,376 | $233K | 8.8% |
| 5 | $169.39 | 1,376 | $233K | 8.8% |
| 6 | $170.21 | 4,526 |
| $770K |
| 29.2% |
| 7 | $170.21 | 4,526 | $770K | 29.2% |
| 8 | $171.42 | 1,018 | $175K | 6.6% |
| 9 | $171.42 | 1,018 | $175K | 6.6% |
| 10 | $171.86 | 205 | $35K | 1.3% |
| Total | $169.95 avg | 15,545 | $2.6M | 100% |
| Filing → |
| TMDX | SELL | 2024-10-17 | $2.1M | — | Filing → |
| TMDX | SELL | 2024-09-17 | $2.6M | — | Filing → |
| TMDX | SELL | 2024-08-23 | $7.8M | — | Filing → |